Measurement of O(6)-alkylguanine-DNA alkyltransferase activity in tumour cells using stable isotope dilution HPLC-ESI-MS/MS
- PMID: 27544051
- DOI: 10.1016/j.jchromb.2016.08.010
Measurement of O(6)-alkylguanine-DNA alkyltransferase activity in tumour cells using stable isotope dilution HPLC-ESI-MS/MS
Abstract
The repair of DNA mediated by O(6)-alkylguanine-DNA alkyltransferase (AGT) provides protection against DNA damage from endogenous or exogenous alkylation of the O(6) position of guanine. However, this repair acts as a double-edged sword in cancer treatment, as it not only protects normal cells from chemotherapy-associated toxicities, but also results in cancer cell resistance to guanine O(6)-alkylating antitumour agents. Thus, AGT plays an important role in predicting the individual susceptibility to guanine O(6)-alkylating carcinogens and chemotherapies. Accordingly, it is necessary to establish a quantitative method for determining AGT activity with high accuracy, sensitivity and practicality. Here, we describe a novel nonradioactive method for measuring AGT activity using stable isotope dilution high-performance liquid chromatography electrospray ionization tandem mass spectrometry (HPLC-ESI-MS/MS). This method is based on the irreversibility of the removal of the O(6)-alkyl group from guanine by AGT and on the high affinity of O(6)-benzylguanine (O(6)-BG) as an AGT substrate. HPLC-ESI-MS/MS was used to measure the AGT activities in cell protein extracts from eight tumour lines, demonstrating that AGT activity was quite variable among different cell lines, ranging from nondetectable to 1021 fmol/mg protein. The experiments performed in intact tumour cells yielded similar results but exhibited slightly higher activities than those observed in cell protein extracts. The accuracy of this method was confirmed by an examination of AGT expression levels using western blotting analysis. To our knowledge, this method is the first mass spectrometry-based AGT activity assay, and will likely provide assistance in the screening of cancer risk or the application of chemotherapies.
Keywords: AGT activity; HPLC-ESI–MS/MS; O(6)-alkylguanine-DNA alkyltransferase; O(6)-benzylguanine; Tumour cells.
Copyright © 2016 Elsevier B.V. All rights reserved.
Similar articles
-
Investigations on the effect of O(6)-benzylguanine on the formation of dG-dC interstrand cross-links induced by chloroethylnitrosoureas in human glioma cells using stable isotope dilution high-performance liquid chromatography electrospray ionization tandem mass spectrometry.Chem Res Toxicol. 2014 Jul 21;27(7):1253-62. doi: 10.1021/tx500143b. Epub 2014 Jun 17. Chem Res Toxicol. 2014. PMID: 24914620
-
Mass spectrometry based approach to study the kinetics of O6-alkylguanine DNA alkyltransferase-mediated repair of O6-pyridyloxobutyl-2'-deoxyguanosine adducts in DNA.Chem Res Toxicol. 2011 Nov 21;24(11):1966-75. doi: 10.1021/tx2002993. Epub 2011 Sep 29. Chem Res Toxicol. 2011. PMID: 21913712 Free PMC article.
-
Quantification of DNA interstrand crosslinks induced by ACNU in NIH/3T3 and L1210 cells using high-performance liquid chromatography/electrospray ionization tandem mass spectrometry.Rapid Commun Mass Spectrom. 2014 Mar 15;28(5):439-47. doi: 10.1002/rcm.6800. Rapid Commun Mass Spectrom. 2014. PMID: 24497281
-
Clinical relevance of MGMT in the treatment of cancer.J Clin Oncol. 2002 May 1;20(9):2388-99. doi: 10.1200/JCO.2002.06.110. J Clin Oncol. 2002. PMID: 11981013 Review.
-
Inactivation of O6-alkylguanine DNA alkyltransferase as a means to enhance chemotherapy.Cancer Treat Rev. 2006 Jun;32(4):261-76. doi: 10.1016/j.ctrv.2006.03.004. Epub 2006 May 15. Cancer Treat Rev. 2006. PMID: 16698182 Review.
Cited by
-
Reductive Activity and Mechanism of Hypoxia- Targeted AGT Inhibitors: An Experimental and Theoretical Investigation.Int J Mol Sci. 2019 Dec 13;20(24):6308. doi: 10.3390/ijms20246308. Int J Mol Sci. 2019. PMID: 31847200 Free PMC article.
-
Synthesis and Antitumor Activity Evaluation of a Novel Combi-nitrosourea Prodrug: BGCNU.ACS Med Chem Lett. 2017 Jan 13;8(2):174-178. doi: 10.1021/acsmedchemlett.6b00358. eCollection 2017 Feb 9. ACS Med Chem Lett. 2017. PMID: 28197307 Free PMC article.
-
Energy Blocker Lonidamine Reverses Nimustine Resistance in Human Glioblastoma Cells through Energy Blockade, Redox Homeostasis Disruption, and O6-Methylguanine-DNA Methyltransferase Downregulation: In Vitro and In Vivo Validation.ACS Pharmacol Transl Sci. 2024 Apr 17;7(5):1518-1532. doi: 10.1021/acsptsci.4c00085. eCollection 2024 May 10. ACS Pharmacol Transl Sci. 2024. PMID: 38751635 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous